🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

115 results for “SINOVAC BIOTECH LTD” Clear

  1. Tetravalent influenza vaccine developed by Sinovac Biotech Co.

    SINOVAC BIOTECH LTD

    Influenza

    phase 3 small molecule active

    1 trial
  2. Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age

    SINOVAC BIOTECH LTD

    Poliomyelitis

    phase 3 mab completed

    1 trial
  3. Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain

    SINOVAC BIOTECH LTD

    COVID-19

    phase 3 mab active

    1 trial
  4. Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14

    SINOVAC BIOTECH LTD

    Covid19

    phase 3 mab completed

    1 trial
  5. Vaccine manufactured at commercialized scale

    SINOVAC BIOTECH LTD

    Varicella

    phase 3 mab completed

    1 trial
  6. Varicella Vaccine

    SINOVAC BIOTECH LTD

    Varicella

    phase 3 mab completed

    1 trial
  7. Varicella Vaccine

    SINOVAC BIOTECH LTD

    Varicella (Chickenpox)

    phase 3 mab active

    1 trial
  8. bivalent enterovirus vaccine (Vero cell), inactivated

    SINOVAC BIOTECH LTD

    Hand, Foot, and Mouth Disease(HFMD)

    phase 3 mab active

    1 trial
  9. experimental vaccine

    SINOVAC BIOTECH LTD

    Epidemic Meningitis

    phase 3 mab active

    4 trials
  10. sIPV-bOPV-bOPV vaccination schedule

    SINOVAC BIOTECH LTD

    Poliomyelitis

    phase 3 mab completed

    1 trial
  11. sIPV-sIPV-bOPV vaccination schedule

    SINOVAC BIOTECH LTD

    Poliomyelitis

    phase 3 mab completed

    1 trial
  12. three consecutive lots of EV71 vaccine

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial
  13. 100U EV71 vaccine with adjuvant

    SINOVAC BIOTECH LTD

    Infection, Viral, Enterovirus

    phase 2 mab completed

    1 trial
  14. 400 U EV71 vaccine with adjuvant

    SINOVAC BIOTECH LTD

    Infection, Viral, Enterovirus

    phase 2 mab terminated

    1 trial
  15. COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)

    SINOVAC BIOTECH LTD

    COVID-19

    phase 2 mab terminated

    1 trial
  16. COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain

    SINOVAC BIOTECH LTD

    COVID-19

    phase 2 mab completed

    1 trial
  17. CoronaVac®

    SINOVAC BIOTECH LTD

    COVID-19

    phase 2 mab completed

    1 trial
  18. Low-dose experimental vaccine

    SINOVAC BIOTECH LTD

    Herpes Zoster

    phase 2 mab active

    1 trial
  19. Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)

    SINOVAC BIOTECH LTD

    Hand, Foot, and Mouth Disease (HFMD)

    phase 2 mab completed

    1 trial
  20. Medium-dose COVID-19 Vaccine(Vero Cell),Inactivated

    SINOVAC BIOTECH LTD

    COVID-19

    phase 2 mab on hold

    1 trial
  21. Oral hexavalent reassortant rotavirus attenuated live vaccine

    SINOVAC BIOTECH LTD

    Rotavirus Gastroenteritis

    phase 2 mab active

    2 trials
  22. SA55 Injection

    SINOVAC BIOTECH LTD

    Infection of Upper Respiratory Tract Caused by 2019-nCoV

    phase 2 small molecule active

    1 trial
  23. SNA02-48

    SINOVAC BIOTECH LTD

    Tetanus

    phase 2 mab active

    1 trial
  24. Single-dose regimen of high dosage investigational sIPV

    SINOVAC BIOTECH LTD

    Poliomyelitis

    phase 2 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources